Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

Share Price is delayed by 15 minutes
Get Live Data
167.40    2.30 (1.39%)
Bid:
167.00
Ask:
167.50
Spread: 0.50 (0.299%)
Market Cap: £1.24b
GRI Live PriceLast checked at - London Stock Exchange

Intraday Grainger plc Share Chart

New Banking Facilities

1 Oct 2009 07:00

RNS Number : 0050A
Grainger PLC
01 October 2009
 



1 October 2009

Grainger plc ("Grainger" or the "Group")

GRAINGER SIGNS NEW BANKING FACILITIES

WITH EXTENDED MATURITIES

Grainger signs £615 million of Forward Start Facilities, significantly strengthening the Group's liquidity profile until December 2012

In its Interim Management Statement of 12 August 2009, Grainger stated that it was in discussions with its lending banks regarding the planned refinancing of certain of its credit facilities.

Grainger now announces that it has successfully signed two new forward start credit facilities totalling £615 million which will provide extended liquidity for the Group at the time that certain of its existing facilities expire. 

These two new facilities comprise a £250 million committed term loan which will become available in June 2010 and a £365 million committed term loan available in June 2011.  They will, on those dates, be used to refinance existing revolving credit facilities of £400 million and £475 milliothat mature on those dates. As a separate matter, those facilities have now been reduced to £250 million and £445 million respectivelywhich the Group has been able to do by utilising excess short-term committed but undrawn facilities.  

Both the new forward start facilities will mature in December 2012.

The other facilities under Grainger's core borrowing agreement are a £228 million revolving credit facility maturing in December 2012 and £425 million of term loans maturing in June 2013. 

As a result of the above, the Group now has no core debt facilities maturing in its financial year to September 2010, with only £109 million maturing in its financial year to September 2011 and only £57 million in its financial year to September 2012.The Group continues to be highly cash generative. 

The method of calculation and limits under the Group's existing financial covenants remain unchanged by the negotiation of these new facilitiesThe Group's headroom as at 30 September was approximately £170 million. 

Following this successful refinancing, Grainger's average cost of debt (based on current LIBOR rates) is 5.5% (previously 4.6%). This would reduce to 5.2% should the Loan to Value ratio on the facilities fall below 60% (67% as at 30 June 2009).

Andrew CunninghamGrainger's Finance Director and Acting Chief Executive Officer, commented: 

"This refinancing results in Grainger having far greater certainty over its medium term financing. Under the old facilities there were aggregate debt repayments of about £90million to be made by June 2011. These are now reduced to about £110 million on 30 June 2011 and a minimal amount in the 18 months after that." 

For further information:

Grainger plc

Financial Dynamics

Andrew Cunningham/Nick On/Dave Butler 

Stephanie Highett/Dido Laurimore

Tel: +44 (0) 191 261 1819

+44 (0) 20 7795 4700

Tel: +44 (0) 20 7831 3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCILFIRADIIVIA
Date   Source Headline
9th Oct 20257:00 amRNSPost-Close Trading Update
8th Oct 202510:35 amRNSDirector/PDMR Shareholding
6th Oct 20253:16 pmRNSDirector/PDMR Shareholding
3rd Oct 20254:39 pmRNSBlock Listing Return
17th Sep 20257:00 amRNS-RFull lease-up at Grainger’s Oxford BTR Scheme
10th Sep 20257:00 amRNS-RRapid 50% lease-up in under a month at Seraphina
8th Sep 20257:00 amRNSSuccessful conversion to REIT status
3rd Sep 20254:20 pmRNSDirector/PDMR Shareholding
2nd Sep 20257:00 amRNSResult of General Meeting
5th Aug 20252:45 pmRNSDirector/PDMR Shareholding
31st Jul 20257:00 amRNSChair Designate Appointment
30th Jul 202510:07 amRNSDirector/PDMR Shareholding
30th Jul 20257:00 amRNSPublication of a Circular and Notice of GM
11th Jul 20251:06 pmRNS-RMello Retail Investor Conference
9th Jul 20252:14 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNS-ROxford scheme achieves c.60% lease up in 3 months
7th Jul 20255:08 pmRNSStandard form for notification of major holdings
3rd Jul 20254:03 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNS-RConstruction completes on latest BTR scheme
24th Jun 20257:00 amRNS-RNew Progressive research note
5th Jun 202512:47 pmRNSDirector/PDMR Shareholding
4th Jun 20259:46 amRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSSuccessful lease up at Millwrights Place
23rd May 20252:56 pmRNSDirector/PDMR Shareholding
21st May 202510:42 amRNSDirector/PDMR Shareholding
15th May 20257:00 amRNSHalf Year Financial Results
6th May 20254:57 pmRNSDirector/PDMR Shareholding
23rd Apr 20257:00 amRNSNotice of Interim Results
11th Apr 20251:34 pmRNSDirector/PDMR Shareholding
2nd Apr 20254:19 pmRNSDirector/PDMR Shareholding
1st Apr 20255:50 pmRNSBlock Listing Return
17th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20259:21 amRNS-RGrainger’s science-based target approved by SBTi
7th Mar 20251:21 pmRNSDirector/PDMR Shareholding
24th Feb 20253:50 pmRNSDirector/PDMR Shareholding
5th Feb 20253:24 pmRNSDirector/PDMR Shareholding
5th Feb 20252:47 pmRNSResult of AGM
5th Feb 20257:00 amRNSTrading Update
22nd Jan 20257:00 amRNS-RInclusion in Dow Jones Sustainability Indices
20th Jan 20258:35 amRNS-RProgressive Initiates Research Coverage
16th Jan 20254:07 pmRNSDirector/PDMR Shareholding
8th Jan 202512:27 pmRNSDirector/PDMR Shareholding
23rd Dec 202412:50 pmRNSDirector/PDMR Shareholding
23rd Dec 202412:48 pmRNSDirector/PDMR Shareholding
19th Dec 20244:42 pmRNSDirector/PDMR Shareholding
19th Dec 20244:37 pmRNSDirector/PDMR Shareholding
13th Dec 20243:50 pmRNSNotice of AGM
10th Dec 20245:24 pmRNSTotal Voting Rights
5th Dec 20244:09 pmRNSDirector/PDMR Shareholding
21st Nov 20247:00 amRNSPreliminary Full Year Financial Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.